Czechia· CZ-0282235
LOTEPREDNOL OLIKLA
A loteprednol product containing loteprednol etabonate, registered in Czechia by Olikla s.r.o., Kostelec nad Černými Lesy. The same ATC class is registered in 6 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Loteprednol is registered in 6 of 19 countries.
Countries holding a registration under ATC S01BA14 (loteprednol), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 3 of them publish a price we can compare per daily dose
Loteprednol · ATC S01BA14
6 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Ireland
- Polandprice
- United Kingdom
The record
At a glance
SÚKL (Czech Republic)- Active substance
- LOTEPREDNOL ETABONATE
- Manufacturer
- Olikla s.r.o., Kostelec nad Černými Lesy
- Country
- Czechia (CZ)
- ATC code
- S01BA14
- ATC class
- Loteprednol
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
57 interactions on record for loteprednol.
Graded by severity as the source publishes them — 16 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Loteprednol · interactions on record
57 records
- 16 moderate
- 41 info
Most severe, free to view
- MiconazoleA07AC01moderate
- KetoconazoleH02CA03moderate
- ErythromycinJ01FA01moderate
- ClarithromycinJ01FA09moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Loteprednol in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesLOTEMAXBausch & Lomb Incorporated
- CanadaALREXBAUSCH & LOMB INC
- PolandLotemax 0,5%Delfarma Sp. z o.o.
- IrelandLotemax 0.5% w/v eye drops, suspensionDr. Gerhard Mann, chem.-pharm. Fabrik GmbH
- GermanyLotemaxDr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh
- BelgiumLotemax 5 mg/mlBausch & Lomb Pharma
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Lotemax
- Cyprus · Lotemax
- Germany · Lotemax
- Estonia · Lotemax
- United Kingdom (Northern Ireland) · Lotemax
- Greece · Lotemax
- Ireland · Lotemax
- Italy · Lotemax, Nolok
- Lithuania · Lotemax
- Poland · Lotemax
- Portugal · Xafex
- Slovenia · Lotemax
- Slovakia · Lotemax, Loteprednol Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/20200874-f2b2-42ea-b17a-96191a5656cc GET /v1/drugs/20200874-f2b2-42ea-b17a-96191a5656cc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "OPH GTT SUS",
"source": "sukl",
"strength": "5MG/ML",
"pack_size": "1X5ML",
"substance": "LOTEPREDNOL ETABONATE",
"cz_kod_sukl": "0282235",
"product_type": "CH",
"substance_codes": "16807",
"registration_state": "R",
"registration_number": "64/543/24-C"
}See everything about loteprednol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.